- Acer Therapeutics (NASDAQ:ACER) -79% after FDA rejects Edsivo application for rare connective tissue disorder.
- More news on: Acer Therapeutics Inc., Cemtrex, Inc., Aldeyra Therapeutics, Inc., Stocks on the move, Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
VivoPower International PLC Company Name:
VVPR Stock Symbol:
Market:
(NewsDirect) Contrary to the numerous mainstream reports that EV demand will be slowing down this year, the market is already showing solid signs of recovery. In China for instance, which is currently the world’s biggest EV market, EVs drove first-quarter sales growth, rising 31.8% to ...
(NewsDirect) VivoPower International PLC (NASDAQ: VVPR, “VivoPower”, the “Company”) has announced that Executive Chairman and CEO, Kevin Chin, is increasing his individual shareholding in the Company by 146,084 shares, representing approximately 4.4% of the undilut...
(NewsDirect) The whole world is on a decarbonization mission amid rising climate change concerns. In fact, the International Energy Agency (IEA) estimates that this year will bring $1.7 trillion worth of investments in deploying renewable energy and other clean-energy technologies—a ne...